Cardiovascular diseases (CVDs) are the leading cause of death around the world, a trend
that will progressively grow over the next decade. Recently, with the advancement of
nanotechnology, innovative nanoparticles (NPs) have been efficiently utilized in disease
diagnosis and theranostic applications. In this review, we highlighted the benchmark
summary of the recently synthesized NPs that are handy for imaging, diagnosis, and
treatment of CVDs. NPs are the carrier of drug-delivery payloads actively reaching more …